1.
Clin Infect Dis
; 32(1): 140-3, 2001 Jan.
Article
in English
| MEDLINE
| ID: mdl-11118393
ABSTRACT
To assess a possible association between antiretroviral treatment and paronychia, we conducted a retrospective cohort study of 288 human immunodeficiency virus-positive protease inhibitor recipients. Indinavir treatment-adjusted for age, sex, CD4 count, diabetes status and other antiretroviral drug exposures-was significantly associated with paronychia of the great toe (hazard ratio 4.7; 95% confidence interval 1.6-13.9).